Atypia of Undetermined Significance (AUS) / Follicular Lesion of Undetermined Significance (FLUS)

Withdrawn before enrolling

Conditions studied: Diagnoses Disease

In brief

According to the guidelines for reporting thyroid fine needle aspirations known as The Bethesda System, the category of atypical cells known as AUS/ FLUS category has an estimated rate of 5 to 15% for malignancy. This study aims to determine the rate of malignancy of this category in our institution and to evaluate the clinical outcome of the participants.

Key facts

Study ID

NCT03224754

Run by

University of Mississippi Medical Center

People needed

0

Starts

2017-07-18

Expected to finish

2018-05-02

Last updated by the study team

2018-05-11

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Thyroid fine needle aspirations interpreted as AUS/ FLUS at University of Mississippi Medical Center from April 2010 to December 2016.

You may not qualify if…

• Fine needle aspirations of thyroid with diagnosis of unsatisfactory, benign, suspicious for follicular neoplasm/ Follicular neoplasm, suspicious for malignancy and malignant.

Where it is running

• University of Mississippi Medical Center — Jackson, Mississippi, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.